By Dan Beckham Strategic direction demands specific language, not vague and overused clichés. The first obligation of a leader is, of course, to lead. But leading always begs a question — toward where? The quality of leadership ultimately must be
All News
LAS VEGAS — Use of bone marrow concentrate containing mesenchymal stem cells as an adjunct therapy showed significant improvement in healing outcomes after rotator cuff repair, according to data presented during the American Academy of Orthopaedic Surgeons Annual Meeting. Researchers
The lower-limb paralysis associated with spina bifida may be effectively treated before birth by combining a unique stem cell therapy with surgery, new research from UC Davis Health System has found. The study, conducted in an animal model, was led
By Shereen Lehman Losing weight in middle age might mean losing not just unwanted fat, but also precious bone density, at least for women, a new study suggests. Regardless of the types of foods or amount of calcium in their
By Caitlyn Belcher Shortly after being diagnosed with hypothyroidism, Centennial Hills resident April Anderson began experiencing numbness and burning sensations in her hands and feet. “It got to the point where I could hardly walk. I could not fill out
By Katie Charles The Specialist An associate professor of orthopedic spine surgery at Mount Sinai, Dr. Andrew Casden treats adults and children with various spinal disorders, including scoliosis, herniated discs, and spinal stenosis from the neck to th…
By William Malm AUSTIN (KXAN) — Osteoporosis, a weakening of bone density, is often thought of as an old women’s disease, but that is not the whole story. A lot of men get it as well, and it can come on
LOS ANGELES — Arthroscopic rotator cuff repair was a highly effective treatment in patients older than 70 years, according to results of a study presented at the Arthroscopy Association of North America Annual Meeting “Arthroscopic rotator cuff repair was highly
Ladenburg Thalmann cut shares of CONMED (NASDAQ:CNMD) from a buy rating to a neutral rating in a research note issued to investors on Friday,TheFlyOnTheWall.com reports. The firm currently has $55.00 price target on the stock. A number of other firms have also recently
CHICAGO–(BUSINESS WIRE)–FH Ortho, maker of thoughtfully designed orthopedic devices, instruments and procedures for orthopedic surgeons around the world, announces it has received approval from The U.S. Food and Drug Administration to market the ARROW Reverse Shoulder “long keel” and “short
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1